Search Within

William Pao

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (11)
Groups
  1. Epidemiology and Biostatistics (27)
  2. Biostatistics Service (24)
  3. Department of Pathology and Laboratory Medicine (20)
  4. GSK Faculty (20)
  5. Human Oncology and Pathogenesis Program (20)
  6. Tow Center for Developmental Oncology (TCDO) (20)

More Groups

People
  1. Marc Ladanyi (19)
  2. Mark Kris (16)
  3. Valerie Rusch (16)
  4. Venkatraman Seshan (14)
  5. Maureen Zakowski (12)
  6. Ronglai Shen (8)

More People

Years
  1. 2011 (1)
  2. 2010 (3)
  3. 2009 (10)
  4. 2008 (3)
  5. 2007 (3)
  6. 2006 (4)

More Years

Publications
  1. Clinical Cancer Research (6)
  2. Journal of Clinical Oncology (5)
  3. Journal of Thoracic Oncology (5)
  4. Cancer Research (2)
  5. Cancer (1)
  6. JNCI: Journal of the National Cancer Institute (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (5)
  4. Nature Publishing Group (3)
  5. American Society for Clinical Investigation (1)
  6. National Academy of Sciences (1)

More Publishers

Results (27)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective trial with preoperative gefitinib to correlate lung cancer response with EGFR exon 19 and 21 mutations and to select patients for adjuvant therapy
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, M. F.; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
    Journal Article

    Pham, D. K.; Kris, M. G.; Riely, G. J.; Sarkaria, I. S.; McDonough, T.; Chuai, S. K.; Venkatraman, E. S.; Miller, V. A.; Ladanyi, M.; Pao, W.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib
    Journal Article

    Riely, G. J.; Pao, W.; Pham, D.; Li, A. R.; Rizvi, N.; Venkatraman, E. S.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.; Miller, V. A.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
    Journal Article

    Milton, D. T.; Azzoli, C. G.; Heelan, R. T.; Venkatraman, E.; Gomez, J. E.; Kris, M. G.; Krug, L. M.; Pao, W.; Rizvi, N. A.; Dunne, M.; more...
    Cancer (2006)

    Fulltext@MSK | Save
  • Estimation of the likelihood of epidermal growth factor receptor (EGFR) mutations based on cigarette smoking history in patients with adenocarcinoma of the lung
    Meeting Abstract

    Pham, D.; Kris, M. G.; McDonough, T.; Riely, G. J.; Venkatraman, E. S.; Pao, W.; Wilson, R. K.; Miller, V. A.; Singh, B.; Rusch, V. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Predicting sensitivity of non-small-cell lung cancer to gefitinib: Is there a role for P-Akt
    Journal Article

    Pao, W.; Miller, V. A.; Venkatraman, E.; Kris, M. G.
    JNCI: Journal of the National Cancer Institute (2004)

    Fulltext@MSK | Save
  • Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer
    Journal Article

    Miller, V. A.; Kris, M. G.; Shah, N.; Patel, J.; Azzoli, C.; Gomez, J.; Krug, L. M.; Pao, W.; Rizvi, N.; Pizzo, B.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save